Lymphedema
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals of both sexes; be over 18 years of age; present lymphedema in lower limbs in stages II or III according to Mowlen (1948)
Exclusion criteria
Exclusion criteria: Patients with lymphedema undergoing treatment with chronic use of oral anti-inflammatory drugs or corticosteroids; with active and untreated infectious processes during study recruitment; who had thrombophlebitis; diabetes; skin rashes; open wounds; urinary and/or fecal incontinence and contraindications for manual lymphatic drainage and for compressive bandaging
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected Outcome 1: Improvement in the concentration of the inflammatory cytokines interferon gamma, tumor necrosis factor alpha, transforming growth factor beta, interleukin 4, interleukin 6 and interleukin 10, as measured by laboratory tests and the multi-analyte method (Multiplex immunoassay method) , collected before and after the 20 intervention sessions | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected Outcome 2: Reduction of the volumetric measurement of the lower limbs, through the truncated cone formula, collected before and after the 20 intervention sessions | — |
Countries
Brazil
Contacts
Universidade Federal de Pernambuco